Article ; Online: [COVID-19 pandemia: Impact on the cariovascular system. Data of 1
Annales de cardiologie et d'angeiologie
2020 Volume 69, Issue 3, Page(s) 107–114
Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells with angiotensin receptors, leading to pneumonia linked to COVID-19. The virus has a double impact on the cardiovascular system, the infection will be more intense if the ... ...
| Title translation | Pandémie COVID-19 : impact sur le systeme cardiovasculaire. Données disponibles au 1 |
|---|---|
| Abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells with angiotensin receptors, leading to pneumonia linked to COVID-19. The virus has a double impact on the cardiovascular system, the infection will be more intense if the host has cardiovascular co-morbidities and the virus can cause life-threatening cardiovascular lesions. Therapies associated with COVID-19 may have adverse cardiovascular effects. Therefore, special attention should be given to cardiovascular protection during COVID-19 infection. |
| MeSH term(s) | Antimalarials/adverse effects ; Antimalarials/therapeutic use ; Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; Azithromycin/adverse effects ; Azithromycin/therapeutic use ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; Cardiomyopathies/virology ; Cardiovascular Diseases/complications ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/prevention & control ; Cerebrovascular Disorders/complications ; Cerebrovascular Disorders/prevention & control ; Cerebrovascular Disorders/virology ; Chloroquine/adverse effects ; Chloroquine/therapeutic use ; Comorbidity ; Coronary Disease/complications ; Coronary Disease/prevention & control ; Coronary Disease/virology ; Coronavirus Infections/complications ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Drug Interactions ; Drug Therapy, Combination/adverse effects ; Female ; Humans ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Male ; Methylprednisolone/adverse effects ; Pandemics/prevention & control ; Pneumonia, Viral/complications ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Risk Factors ; SARS-CoV-2 ; Virus Internalization/drug effects |
| Chemical Substances | Antimalarials ; Antiviral Agents ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Hydroxychloroquine (4QWG6N8QKH) ; Azithromycin (83905-01-5) ; Chloroquine (886U3H6UFF) ; Methylprednisolone (X4W7ZR7023) |
| Keywords | covid19 |
| Language | French |
| Publishing date | 2020-04-07 |
| Publishing country | France |
| Document type | Journal Article ; Review |
| ZDB-ID | 418425-7 |
| ISSN | 1768-3181 ; 0003-3928 |
| ISSN (online) | 1768-3181 |
| ISSN | 0003-3928 |
| DOI | 10.1016/j.ancard.2020.04.001 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.B 47: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 216: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.